hydroxychloroquine has been researched along with folic acid in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (40.00) | 29.6817 |
| 2010's | 3 (30.00) | 24.3611 |
| 2020's | 3 (30.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Ahn, MJ; Bae, SC; Choi, BR; Jun, JB; Kim, TH; Lee, WS | 1 |
| Chandrashekara, S; Patil, R; Shobha, A; Vadiraja, HS | 1 |
| Cleland, LG; Gillis, D; Hissaria, P; James, HM; Lester, S; Proudman, SM; Somogyi, AA | 1 |
| Erov, NK; Sergiets, NA | 1 |
| Buche, AS; Kini, SH; Londhey, VA; Rajadhyaksha, GC | 1 |
| Bergstrom, A; Bird, HA | 1 |
| de Mattos, ABN; Furian, MEA; Garbo Baroni, L; Zanotto, LL | 1 |
| Bhattacharyya, A; Kaur, H; Kumar, S; Medhi, B; Prajapat, M; Prakash, A; Sarma, P | 1 |
| Ahmanna Chakir, F; Dudler, J; Folly, A | 1 |
2 review(s) available for hydroxychloroquine and folic acid
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
[Methotrexate use: untangling the real from the fake].
Topics: Antirheumatic Agents; Folic Acid; Humans; Hydroxychloroquine; Methotrexate | 2021 |
2 trial(s) available for hydroxychloroquine and folic acid
| Article | Year |
|---|---|
The incidence of Proteus mirabilis infection increases in patients on treatment but does not trigger disease activity.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Bacterial; Antibody Specificity; Antirheumatic Agents; Arthritis, Rheumatoid; Female; Folic Acid; Follow-Up Studies; Humans; Hydroxychloroquine; Immunoglobulins; Male; Methotrexate; Middle Aged; Proteus Infections; Proteus mirabilis; Remission Induction; Serologic Tests; Steroids | 2006 |
[Combined basic therapy of rheumatoid arthritis with methotrexate and plaquenil].
Topics: Adolescent; Adult; Aged; Antirheumatic Agents; Arthritis, Rheumatoid; Drug Therapy, Combination; Female; Folic Acid; Humans; Hydroxychloroquine; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Young Adult | 2009 |
6 other study(ies) available for hydroxychloroquine and folic acid
| Article | Year |
|---|---|
Acute erythroleukemia in a rheumatoid arthritis patient during low-dose methotrexate therapy.
Topics: Aged; Antirheumatic Agents; Arthritis, Rheumatoid; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Folic Acid; Humans; Hydroxychloroquine; Leukemia, Erythroblastic, Acute; Methotrexate; Treatment Outcome | 2005 |
Common polymorphisms in the folate pathway predict efficacy of combination regimens containing methotrexate and sulfasalazine in early rheumatoid arthritis.
Topics: Adult; Aged; Antirheumatic Agents; Arthritis, Rheumatoid; Drug Therapy, Combination; Female; Folic Acid; Gene Frequency; Genotype; Haplotypes; Health Status; Humans; Hydroxychloroquine; Male; Methotrexate; Middle Aged; Polymorphism, Single Nucleotide; Predictive Value of Tests; Severity of Illness Index; Sulfasalazine; Tetrahydrofolate Dehydrogenase | 2008 |
Kikuchi fujimoto disease and systemic lupus erythematosus--a rare association.
Topics: Adult; Female; Folic Acid; Histiocytic Necrotizing Lymphadenitis; Humans; Hydroxychloroquine; Lupus Erythematosus, Systemic; Lymph Nodes; Prednisolone; Treatment Outcome | 2010 |
A dancer with rheumatoid arthritis: a role for biologics.
Topics: Arthritis, Rheumatoid; Biological Products; Dancing; Drug Therapy, Combination; Female; Folic Acid; Humans; Hydroxychloroquine; Methotrexate; Treatment Outcome; Young Adult | 2013 |
Subacute cutaneous lupus erythematosus triggered after measles vaccination.
Topics: Antirheumatic Agents; Drug Therapy, Combination; Female; Folic Acid; Follow-Up Studies; Glucocorticoids; Humans; Hydroxychloroquine; Lupus Erythematosus, Cutaneous; Lupus Erythematosus, Systemic; Measles; Methotrexate; Middle Aged; Prednisone; Vaccination; Vitamin B Complex | 2021 |
Folic acid as placebo in controlled clinical trials of hydroxychloroquine prophylaxis in COVID-19: Is it scientifically justifiable?
Topics: Angiotensin-Converting Enzyme 2; COVID-19; COVID-19 Drug Treatment; Folic Acid; Humans; Hydroxychloroquine; Hyperhomocysteinemia; Hypertension, Pulmonary; Methylenetetrahydrofolate Reductase (NADPH2); Models, Theoretical; Nitric Oxide Synthase Type III; Placebos; Protein Binding; Randomized Controlled Trials as Topic; Research Design | 2021 |